Header cover image

Taiwanese (TAIEX) Healthcare Services Industry Analysis

UpdatedApr 17, 2025
DataAggregated Company Financials
Companies23
  • 7D10.7%
  • 3M-7.2%
  • 1Y-18.1%
  • YTD-10.5%

Over the last 7 days, the Healthcare Services industry has risen 5.9%, driven by gains from Universal Vision Biotechnology of 14%. However, the industry is down 17% over the past year.

Industry Valuation and Performance

Has the Taiwanese Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 17 Apr 2025NT$78.4bNT$41.2bNT$2.7b18.4x29.4x1.9x
Sat, 15 Mar 2025NT$86.6bNT$40.9bNT$2.6b19.3x33.9x2.1x
Mon, 10 Feb 2025NT$87.8bNT$41.2bNT$2.7b20.8x32.6x2.1x
Wed, 08 Jan 2025NT$86.1bNT$39.9bNT$2.9b20.2x30x2.2x
Fri, 06 Dec 2024NT$89.9bNT$39.9bNT$2.9b19.6x31.4x2.3x
Sun, 03 Nov 2024NT$81.7bNT$39.4bNT$2.8b22.6x29.1x2.1x
Tue, 01 Oct 2024NT$86.9bNT$39.4bNT$2.8b23.2x30.9x2.2x
Thu, 29 Aug 2024NT$84.5bNT$39.6bNT$2.8b23.3x30x2.1x
Sat, 27 Jul 2024NT$86.7bNT$38.9bNT$2.8b21.7x31.2x2.2x
Mon, 24 Jun 2024NT$87.8bNT$38.9bNT$2.8b24.1x31.6x2.3x
Wed, 22 May 2024NT$86.5bNT$39.0bNT$2.8b20.6x31.3x2.2x
Fri, 19 Apr 2024NT$86.4bNT$38.9bNT$2.8b21.3x30.5x2.2x
Sun, 17 Mar 2024NT$87.8bNT$38.8bNT$3.0b22.9x29.7x2.3x
Tue, 13 Feb 2024NT$87.5bNT$37.9bNT$2.8b23.4x31.3x2.3x
Thu, 11 Jan 2024NT$86.5bNT$37.1bNT$2.8b23.1x31.4x2.3x
Sat, 09 Dec 2023NT$83.8bNT$37.1bNT$2.8b24x30.4x2.3x
Mon, 06 Nov 2023NT$84.6bNT$37.0bNT$2.9b24.2x29.1x2.3x
Wed, 04 Oct 2023NT$90.6bNT$37.0bNT$2.9b25x31.1x2.4x
Fri, 01 Sep 2023NT$89.0bNT$37.0bNT$2.9b24.5x30.6x2.4x
Sun, 30 Jul 2023NT$93.7bNT$37.4bNT$3.0b23.5x31.5x2.5x
Tue, 27 Jun 2023NT$94.0bNT$37.3bNT$3.0b24.4x31.8x2.5x
Thu, 25 May 2023NT$94.0bNT$37.0bNT$3.1b22.9x30.5x2.5x
Sat, 22 Apr 2023NT$90.0bNT$36.8bNT$3.0b19.2x29.6x2.4x
Mon, 20 Mar 2023NT$85.7bNT$36.4bNT$3.3b18.6x26x2.4x
Wed, 15 Feb 2023NT$79.6bNT$36.5bNT$3.3b18x24.1x2.2x
Fri, 13 Jan 2023NT$73.7bNT$36.5bNT$3.3b17.2x22.3x2x
Sun, 11 Dec 2022NT$69.7bNT$36.5bNT$3.3b16.8x21.1x1.9x
Tue, 08 Nov 2022NT$64.2bNT$35.7bNT$3.2b16.2x20.3x1.8x
Thu, 06 Oct 2022NT$68.5bNT$35.4bNT$3.1b18x21.9x1.9x
Sat, 03 Sep 2022NT$75.0bNT$35.4bNT$3.1b19.5x24x2.1x
Mon, 01 Aug 2022NT$70.1bNT$33.7bNT$2.9b17.5x24.6x2.1x
Wed, 29 Jun 2022NT$66.4bNT$33.6bNT$2.9b19.1x22.7x2x
Fri, 27 May 2022NT$63.0bNT$33.6bNT$2.9b18.3x21.5x1.9x
Sun, 24 Apr 2022NT$66.6bNT$33.1bNT$2.8b20.9x23.5x2x
Price to Earnings Ratio

23.5x


Total Market Cap: NT$66.6bTotal Earnings: NT$2.8bTotal Revenue: NT$33.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Healthcare Services Industry Price to Earnings3Y Average 28.2x202320242025
Current Industry PE
  • Investors are relatively neutral on the Taiwanese Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 28.2x.
  • The 3-year average PS ratio of 2.2x is higher than the industry's current PS ratio of 1.9x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 7.5% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market12.19%
Healthcare13.13%
Healthcare Services10.68%
Healthcare Services13.19%
Healthcare Distributors9.26%
Healthcare Facilities2.15%
Industry PE
  • Investors are most optimistic about the Healthcare Facilities industry which is trading above its 3-year average PE ratio of 59.8x.
    • It looks like they are confident that earnings will grow faster in the future than they have historically.
  • Investors are most pessimistic about the Healthcare Distributors industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 24.2x.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4164 CHC Healthcare GroupNT$43.9011.6%
+NT$759.2m
-24.3%PE43.5x
3218 Universal Vision BiotechnologyNT$181.503.1%
+NT$466.0m
-29.0%PE14.4x
6130 Shangya TechnologyNT$37.1032.0%
+NT$398.7m
66.0%PS8x
4104 Excelsior MedicalNT$88.501.5%
+NT$212.4m
-1.8%PE18.7x
6637 Medical ImagingNT$74.407.4%
+NT$124.0m
-18.8%PE11x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4104

NT$88.50

Excelsior Medical

7D

1.5%

1Y

-1.8%

4173

NT$22.25

Arich Enterprise

7D

-11.2%

1Y

1.8%

1784

NT$70.60

BIONET

7D

2.9%

1Y

23.3%

8403

NT$27.05

ShareHope Medicine

7D

3.0%

1Y

-11.7%

6744

NT$18.20

Feng Chi Biotech

7D

-1.6%

1Y

-21.0%

3218

NT$181.50

Universal Vision Biotechnology

7D

3.1%

1Y

-29.0%

6615

NT$32.25

Sofiva GenomicsLtd

7D

-1.7%

1Y

-20.7%

6637

NT$74.40

Medical Imaging

7D

7.4%

1Y

-18.8%

4164

NT$43.90

CHC Healthcare Group

7D

11.6%

1Y

-24.3%

6931

NT$57.00

Qing Song HealthLtd

7D

-7.0%

1Y

-41.5%

6879

NT$48.00

TCI GENE

7D

6.5%

1Y

-38.1%

6665

NT$19.00

Healthconn

7D

-0.3%

1Y

-26.8%

4724

NT$14.85

Meribank Biotech

7D

-5.4%

1Y

-60.3%

4178

NT$30.05

StemCyte International

7D

-1.5%

1Y

n/a

6518

NT$23.05

Concord Medical

7D

-4.0%

1Y

-3.8%

6130

NT$37.10

Shangya Technology

7D

32.0%

1Y

66.0%